Transcript Highlights:

• In addition to our nursing and human services programs, our allied health programs are doing well.
• Do you do that for the other health care-related programs, behavioral health programs?
• So, your program here is a two-year program for the... The RN, is that correct?
• program.
• Health offices for treatment.

Transcript Highlights:

• , and opioid treatment programs.
• </c> the compulsive gambling treatment the compulsive gambling treatment program<00:36:45.280><c> and
• </c> and requirements and opioid treatment and requirements and opioid treatment programs<00:37:41.119
• work program, payment for care and treatment, and county financial liability.
• work program, payment for care and treatment, and county financial liability.

Keywords: 1183, house

Transcript Highlights:

• center or a substance use treatment program elsewhere, so people can access them closer to... ...where
• So that, in addition to the substance use treatment programs, of course.
• completing a substance use treatment or recovery program?
• So sometimes I work in their opioid treatment programs. I go down and see patients there.
• So that we can get them into treatment and help support those programs.

Summary: The task force meeting opened with a brief organizational update, including new leadership, roll call, and an explanation of the task force’s statutory duties: to study current and future drug and substance use in Missouri, explore solutions, draft or modify legislation, and report recommendations on prevention and treatment. The chair outlined the summer hearing plan, which would feature field experts, with future sessions expected to cover alternative therapies such as psilocybin and ibogaine and testimony from the Department of Mental Health. Members were encouraged to think about legislative ideas and policy recommendations for the upcoming session. The first major testimony came from Dr. Rachel Winograd, who described Missouri’s overdose crisis as evolving into a “fourth wave” marked by fentanyl mixed with animal tranquilizers such as xylazine and medetomidine, along with methamphetamine and other synthetic drugs. She said overdose deaths have declined for a third straight year, with preliminary 2025 data around 1,200 deaths, but emphasized that the crisis remains severe. Her main recommendations were to focus on demand reduction rather than repeated supply crackdowns, expand evidence-based treatment—especially methadone and buprenorphine—broaden naloxone access, and improve practical supports like housing, transportation, and case management. She also said peer services are valuable but should not be used as a substitute for clinical care, and noted that Missouri Medicaid generally covers evidence-based treatment but reimbursement for peer recovery services remains a gap. Dr. Heidi Miller, the state medical director at the Department of Health and Senior Services, reinforced the call for integrating substance use disorder care into whole-person health care. She highlighted the state naloxone standing order, which supports more than 11,000 Medicaid naloxone prescriptions annually, and urged five best practices: integrating SUD treatment into primary care, maternal health, general medical training, EMS initiation of buprenorphine after overdose, and expanded methadone access. She also argued for team-based reimbursement, stronger parity enforcement between behavioral health/SUD and physical health, and caution in regulating emerging substances so policy does not outrun the science. Dr. Doug Burgess of University Health in Kansas City echoed the integration theme, arguing that Missouri’s system is too fragmented and that patients are often stabilized and then left to coordinate their own next steps. He compared ideal SUD care to the coordinated response used for heart attacks, with seamless transitions from emergency care to inpatient treatment, rehab, and outpatient follow-up. He said treatment courts can be effective when they are well coordinated and informed by addiction science, and he stressed the importance of discharge planning, peer recovery coaches, information-sharing, and maintaining Medicaid coverage during justice involvement. No formal votes or committee actions were taken during this portion of the meeting.

Transcript Highlights:

• they go to their program for residential treatment, or they might be held there for things like a firearm
• treatment programs.
• The last treatment I'll talk about is mental health treatment. And Dr. Klein...
• The last treatment I'll talk about is mental health treatment, and Dr.
• programs: the Franklin Covey 7 Habits on the Inside program.

Summary: The Justice Budget Committee heard detailed presentations from the Department of Juvenile Justice and the Department of Corrections on staffing, services, and budget needs. DJJ Secretary Hall emphasized that the agency’s main public safety strategy is education, along with prevention and recidivism reduction. He described major staffing improvements after pay increases for probation, detention, residential care, and prevention workers, and outlined DJJ’s mental health, aftercare, and education continuum, including the Florida Scholars Academy and Florida Youth College. He said the new statewide education model is showing early gains in progress monitoring, high school graduation, and postsecondary enrollment, while also noting ongoing operational issues such as IT connectivity, rural staffing gaps, and the need for geographic pay adjustments for teachers. He also discussed detention center replacement plans in Hillsborough, Broward, and Palm Beach, and said DJJ would transition the Broward JAC to a security contractor after the sheriff’s office pulls sworn officers from the site. Members asked about campus performance differences, teacher pay, detention education quality, and concerns about the rollout and leadership of the Scholars Academy. Hall said some campuses face rural access and infrastructure problems, but the blended learning model provides continuity when internet or staffing issues arise. He defended the superintendent’s qualifications and said early problems with inappropriate online content were addressed. Representative Porras raised concerns about educational quality and the superintendent’s past disciplinary history, while Representative Barrera urged more mentorship and fatherhood-focused programming in juvenile facilities. DOC Secretary Dixon said the prison system is under pressure from rising inmate populations, staffing shortages, and overtime costs. He argued that the system needs funded posts for every functioning housing unit, noting that the department has added housing units without enough staff and now relies heavily on overtime, mobile officer deployments, and shift conversions to keep facilities operating safely. He highlighted that many officers are new, that outside-hospital transports have risen sharply, and that mental health units require additional staffing. DOC’s mental health chief described a large and growing treatment system with outpatient, inpatient, intensive outpatient, and court-ordered services, saying about a quarter of the prison population has a diagnosed mental illness. Community corrections staff described treatment programs, employment specialists, mobile probation and reentry units, and a new mental health first aid training initiative. Reentry staff reported expanded substance abuse, education, CTE, chaplaincy, and digital learning programs, including Edovo and a forthcoming Work Bay platform. No votes were taken.

Transcript Highlights:

• We have many great programs and facilities where patients can get treatment for substance use, but like
• Treatment criteria for certified outpatient alcohol and other drug programs.
• Thirty other states have already begun implementing ASAM standards across their different treatment programs
• This program is, this bill is not trying to eradicate the 340B program.
• the Medi-Cal program.

Summary: The Assembly Health Committee met on April 22 and took up a special order of bills focused largely on prior authorization and utilization management in health care. The chair framed the discussion as part of a broader legislative effort to reduce delays and barriers to care, especially in behavioral health, chronic disease management, cancer treatment, and rehabilitation services. AB 384 by Assembly Member Connolly would prohibit prior authorization for inpatient mental health or substance use emergency admissions and related physician care; supporters said it would prevent dangerous delays in crisis care, while insurers and health plans warned about fraud, abuse, and ambiguity around residential treatment facilities. The bill was moved on a due pass as amended motion and passed the committee on a party-line style vote, with Republicans largely absent or not voting. The committee then heard AB 510 by Assembly Member Addis, which would require health plans, upon request, to provide a peer reviewer of the same or similar specialty when a treating provider appeals a prior authorization denial or modification. Supporters argued that specialty-matched review would make appeals fairer and more clinically informed; opponents said the requirement was too rigid and that timelines and electronic submission rules needed changes. After discussion about the need for timely, specialty-specific review, the bill was approved on a due pass as amended motion and placed on call. AB 539 by Assembly Member Schiavo would extend prior authorization approvals to one year or the duration of the physician’s prescribed treatment for chronic conditions; supporters cited repeated denials and treatment interruptions, while opponents raised concerns about overbreadth, fraud, and the need for shorter validity periods. The bill was also passed as amended and placed on call. The committee next considered AB 669 by Assembly Member Haney, which would bar concurrent and retrospective review for the first 28 days of medically necessary substance use disorder treatment and limit prior authorization for related outpatient medications. The bill was presented with a powerful personal story from Ryan Matlock’s mother about her son’s death after an insurer cut off treatment early; supporters said the measure would keep patients in care long enough to stabilize, while opponents argued it would reduce oversight and could allow lower-quality or non-evidence-based care. The bill was moved on a due pass as amended motion and placed on call. Finally, AB 512 by Assembly Member Harabedian would shorten prior authorization response times to 24 hours for urgent requests and 48 hours for non-urgent requests; supporters said delays can worsen outcomes, while opponents warned the timelines were unrealistic and could increase administrative burdens and safety issues. The bill was approved as amended and placed on call. AB 574 by Assembly Member Mark Gonzalez was then heard; it would allow up to 12 medically necessary physical therapy sessions for a new episode of care without prior authorization, with supporters emphasizing stroke and neurological recovery and opponents warning of reduced oversight and unnecessary care. The transcript ends during testimony on AB 574, before final action is shown.

Transcript Highlights:

• in licensed treatment facilities.
• House Bill 4200, An Act authorizing a pilot program for the use of psychedelics in licensed treatment
• forward with psychedelic treatment.
• A drug stewardship program is basically a program that takes unused medications and safely disposes of
• Traditional treatments such as talk therapy, medications, and inpatient programs often fail to reach

Keywords: 995, all

Summary: The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback. A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use. The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care. Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.

Transcript Highlights:

• They're not about denying treatment.
• worker's treatment.
• The delayed treatment that these medical treatment guidelines result in often produces worse outcomes
• The delayed treatment that these medical treatment guidelines results in.
• The delayed treatment that these medical treatment guidelines results in often produces worse outcomes

Summary: The committee first held a public hearing on Senate Bill 6136, which would require Labor and Industries to publish actuarial indicated workers’ compensation rates for each risk class and disclose when rate increases are capped below those indicated levels. The sponsor and supporters from the hospitality, retail, business, and construction sectors said the bill would improve transparency about how rates are set and how reserve funds and investment earnings are used to hold down premiums. L&I testified that the bill would require publication of a large amount of rate-setting information, but said it was already developed in the normal process and that the bill had no fiscal impact. Questions focused on reserve use, advisory committee involvement, and how the actuarial calculations interact with investment returns. The committee then moved to executive session and took action on several bills, adopting substitutes or amendments and advancing bills including SB 5292, 6014, 5972, 5869, 5874, 6058, 6039, 5944, and 6180, with most sent to Rules and SB 5292 sent to Ways and Means. The committee then heard Senate Bill 5847, which would expand injured workers’ access to medical care by allowing treatment outside the L&I provider network when no provider is available nearby, limiting employer steering to specific providers, shortening utilization review timelines, allowing provider deviation from L&I guidelines when medically appropriate, and expanding continued treatment and cancer monitoring. Labor and worker advocates argued the bill would better reflect the Murray decision and reduce delays in care, while L&I and employer groups said the current evidence-based guideline system works for most claims and warned the bill could weaken quality controls, create vague standards, and increase costs. Testimony also raised concerns about the 15-mile access rule, the employer communication restrictions, and the appeal process for provider removal. The sponsor said the goal was to improve individualized care and continue working with stakeholders. Finally, the committee heard Senate Bill 6067, which would change workers’ compensation time-loss calculations so that 100% of the employer-paid health insurance contribution is included in the benefit calculation instead of the current partial inclusion. Supporters said the bill would help injured workers keep health coverage during recovery and reduce pressure to choose between medical care and income, while opponents argued it would not guarantee the money is actually used for health insurance, could be diverted to other uses or attorney fees, and would significantly increase costs for employers and the accident fund. L&I said the bill would require IT and administrative changes and estimated substantial ongoing benefit costs. The hearing ended without further action on SB 6067, and the chair closed the session after public testimony concluded.

Transcript Highlights:

• I've completed many programs.
• I felt forced to encourage individuals to stay in specific treatment programs because of the threat of
• Once he was found, the lack of bed availability forced him into a treatment program that did not meet
• This program is inspired by research and programs in other states.
• This program is inspired by research and programs in other states.

Keywords: 995, all

Summary: The Joint Committee on the Judiciary held a lengthy hearing on several juvenile justice and parole-related bills, with much of the testimony focused on H. 2051/S. 1087 to end lifetime parole for juveniles and emerging adults, and H. 1923 to raise the age of juvenile court jurisdiction to include 18-, 19-, and 20-year-olds. Chairs Brandy Fluker-Reid and Lydia Edwards opened the hearing by noting the large number of bills and witnesses, the need to keep testimony moving, and special procedures for incarcerated witnesses and sensitive testimony. They also acknowledged the historic nature of the hearing being chaired by two Black women attorneys. No votes were taken during the hearing itself. Many incarcerated speakers and advocates supported ending lifetime parole, arguing that young people can change, that lifetime supervision creates constant fear of technical violations, and that it undermines rehabilitation, family stability, employment, and reintegration. Several testified about their own trauma, youth, and growth in prison programs, while others emphasized the costs of decades of supervision and the racial disparities in the system. Support also came from elected officials, UTEC, the Transformational Prison Project, United Way, CPCS’s Youth Advocacy Division, the Massachusetts Coalition to Prevent Gun Violence, and others, who said juvenile systems are better suited to developmentally appropriate treatment and that the bills would improve public safety and reduce recidivism. There was also opposition, including testimony from family members of a murder victim who argued that lifetime parole should remain for serious violent crimes and that some offenders are not sufficiently rehabilitated. One virtual witness described a family tragedy involving the kidnapping and murder of her infant nephew and warned that ending lifetime parole could remove needed long-term supervision for dangerous offenders. In addition to the juvenile justice bills, the committee heard testimony on H. 1867, a bill related to continuing care for severe mental illness, and H. 2063, which would increase penalties for assaults on correction officers and other prison staff; the correction officers’ union supported H. 2063 and related safety bills. The hearing continued with many more witnesses and bill topics, but no final committee action was announced in the portion provided.

Transcript Highlights:

• AT CHESAPEAKE BAY PROGRAMS SHOW SUCCESS FOR THAT PROGRAM.
• YOU GET INCREASED TREATMENT LEVELS.
• WASTEWATER TREATMENT PLANTS.
• THE NEXT PROGRAM THEY HAD WAS HERNANDO COUNTY SEPTIC TANK PROGRAM.
• THEY HAVE A SEPARATE PROGRAM AND THEY ALSO USE STATE PROGRAMS TO MOVE FORWARD WITH THEIR FOLKS.

Keywords: 999, senate, all

Transcript Highlights:

• Whitehall Campus provides treatment through two programs.
• Whitehall Campus provides treatment through two programs.
• , safe and caring environments, nonlinear treatment gains, responsibility, and evidence-based programming
• sure that all of our programs are receiving the level of care, treatment planning, and engagement that
• But a residential treatment program is very different, so what it would take to bring that building up

Keywords: 956, all

Transcript Highlights:

• Whitehall Campus provides treatment through two programs.
• Whitehall Campus provides treatment through two programs.
• , safe and caring environments, nonlinear treatment gains, responsibility, and evidence-based programming
• sure that all of our programs are receiving the level of care, treatment planning, and engagement that
• But a residential treatment program is very different, so what it would take to bring that building up

Summary: The Health and Human Services Committee held an invited-testimony hearing on LR 425, which examines the Whitehall campus in Lincoln and possible long-term options for youth currently served there. Chair Brian Hardin explained that Whitehall houses two separate programs for adolescent males: a substance use program and a youth-who-sexually-harm program. Testimony from DHHS officials described Whitehall as a Joint Commission-accredited psychiatric residential treatment facility (PRTF) that provides about 40 hours of weekly programming, family involvement, school services, and community reintegration activities. Officials said the department is evaluating whether the programs should remain at Whitehall or move to another state-owned facility, with Hastings described as the department’s preferred alternative because it is more residential in design than a youth rehabilitation treatment center (YRTC).

Transcript Highlights:

• So it is a headhunter program.
• The program is reaching now... I appreciate this bill. The program is reaching out.
• residential treatment programs, adolescent detoxification facilities, and step-down facilities for youth
• Short-term treatment.
• The program, to me...

Keywords: 996, all

Transcript Highlights:

• </c> treatment. 95%. treatment. 95%.
• . treatment. treatment.
• </c> for treatment options. for treatment options.
• </c> and treatments. and treatments.
• Now, that massive gap is why you can see that under these state programs sometimes, treatments are available

Keywords: 1191, senate, all

Transcript Highlights:

• The error of inquiry, as a reminder, the availability of effective outreach and treatment programs for
• and outreach programs and services.
• and outreach programs and services.
• Narcan and other treatments.
• Two sections together on how we can increase the understanding of these outreach and treatment programs

Keywords: 1212, all

Summary: The special commission on xylazine met virtually, called to order by House Chair Mindy Domb, with a quorum present. The commission approved the minutes from its December 11 public meeting and then reviewed the first draft of its final report, which is due to the Legislature by March 30, 2026. Staff explained the report structure, including a commission overview, findings and recommendations from each working group, and appendices with meeting materials and public resources. Commissioners discussed the distinction between licit veterinary xylazine and illicit xylazine in the drug supply, noting that the illicit supply is generally not diverted from legal veterinary sources but obtained through online vendors, and they clarified that xylazine is already classified in Massachusetts as a Schedule 6 substance, so the policy question is whether additional scheduling or penalties are warranted. For the best practices and enforcement section, staff recommended stronger guidance on secure storage and recordkeeping for authorized users, better reporting of diversion, theft, and suspicious orders, and focused enforcement on illicit production and fentanyl trafficking rather than individual possession. Commissioners suggested adding coordination among public safety, law enforcement, and the Attorney General’s office, as well as a state-level approach to emerging drug threats. In the outreach and treatment section, the draft emphasized that existing harm reduction, wound care, naloxone, and mobile outreach programs are effective but need broader coordination, more trauma-informed care, and better education for providers and first responders. Commissioners raised concerns about provider familiarity with xylazine, the need for first responders to include fire personnel and EMS, and the importance of not turning away people with xylazine-related wounds from recovery or treatment settings. The education and training section identified four target audiences: first responders, clinicians, non-clinicians in treatment and outreach settings, and people who use drugs and their families. The draft recommended tailored, stigma-free training and educational materials for each group, with consistent updates, continuing education credits where appropriate, and better access to centralized, real-time data on xylazine and other emerging contaminants. Commissioners discussed the need for centralized reporting and public health surveillance, including existing tools like the BSAS dashboard and StreetCheck, and several members urged the commission to recommend a DPH task force or similar body to monitor future drug supply threats. The meeting ended with staff outlining next steps: a revised draft would be circulated by the end of the week, feedback would be incorporated into a second draft by March 2, and the commission planned to vote on the final report at its March 9 meeting, with a backup meeting later in March if needed.

Transcript Highlights:

• Senate File 1858 is the Market Bucks program.
• </c> programs and and people really enjoy it. programs and and people really enjoy it.
• </c><00:19:08.960><c> One</c> Direct care and treatment as a standalone agency.
• Direct care and treatment has 5,000 employees.
• ,</c><00:23:06.320><c> uh,</c> Services, direct care and treatment, uh, Services, direct care and treatment

Keywords: 1187, senate, all

Transcript Highlights:

• and supervision program.
• and supervision program.
• Also, are there special kinds of treatment programs that you would get at TCCO that you wouldn't get
• program, and their program actually dovetails into our program so that the individuals who are civilly
• program.

Bills: HB1826, HB1969, HB2708, HB2729, HB3618, HB4515, HB4764, SB1021, SB1610

Keywords: mental health, women's health, county jail, depression screening, criminal justice, inmate release, identification certificate, Texas Department of Corrections, personal identification, driver's license, state law, reentry services, nondisclosure, criminal history, criminal defendants, community supervision, misdemeanors, felonies, rehabilitation, hearsay

Summary: The Corrections Committee first took up pending business and reported several previously heard bills favorably to the full House, including HB 1515 and SB 2405, the TDCJ Sunset bill and its Senate companion, HB 5639 on the veteran housing program, HB 2854 on hospital visits as a parole or mandatory supervision condition and related hospital liability, and SB 1080 on occupational licenses for people with criminal convictions. The committee also heard and advanced SB 1080 without amendment, then moved into new business. A major portion of the meeting focused on HB 3618, which would limit invasive group strip searches of female inmates in TDCJ facilities. Formerly incarcerated women and advocates testified in support, describing humiliation, trauma, barriers to programming, and arguing that searches were often ineffective and that contraband more often comes from staff. TDCJ’s resource witness said the agency has looked at technology such as millimeter scanners and is in the process of placing them in facilities, while the bill sponsor said the measure would preserve searches in emergencies and require female officers when women are unclothed. HB 3618 was left pending. The committee also heard HB 4515 on expanding orders of nondisclosure, with the author saying the committee substitute would narrow the bill to marijuana possession only; supporters from Alliance for Safety and Justice and Right on Crime argued it would improve reentry and public safety, while members asked about eligibility and related offenses. HB 1826, requiring depression screenings for pregnant and postpartum incarcerated women, drew support from women’s health advocates and formerly incarcerated witnesses; the bill was left pending. HB 1969, to help people leaving prison renew or obtain driver’s licenses, and HB 2708, expanding nondisclosure eligibility for certain misdemeanor convictions, were also laid out and left pending. Later, the committee heard HB 2729, which would bar hearsay evidence in hearings on violations of release conditions, and SB 1021, which would make stalking convictions ineligible for community supervision and add related victim-protection provisions; both were left pending. SB 1610, addressing civil commitment facility safety, sex offender registration, and penalties for assaults on staff, drew strong opposition from civil commitment residents, family members, and civil rights advocates who argued it was punitive and raised due process concerns; the resource witness said assaults had increased and explained the civil commitment process and existing legal safeguards. Finally, HB 4764 would require TDCJ to report detailed annual data on restrictive housing; supporters said the bill would improve transparency around solitary confinement, and the committee left it pending before adjourning.

Transcript Highlights:

• , where you have a program that is tasked with having a treatment program for individuals who have been
• , where you have a program that is tasked with having a treatment program for individuals who have been
• , where you have a program that is tasked with having a treatment program for individuals who have been
• , where you have a program that is tasked with having a treatment program for individuals who have been
• /c><00:50:23.160><c> for</c> with uh having a treatment program for with uh having a treatment program

Keywords: 1187, senate, all

Transcript Highlights:

• The error of inquiry, as a reminder, the availability of effective outreach and treatment programs for
• and outreach programs and services.
• The area of inquiry, as a reminder, the availability of effective outreach and treatment programs for
• and outreach programs and services.
• Narcan and other treatments.

Summary: The Special Commission on xylazine convened a public meeting to review and discuss the first draft of its final report, approve prior minutes, and gather feedback for revisions. The commission first approved the December 11 minutes by roll call vote, then reviewed the report structure, which will include a commission overview, working group findings and recommendations, and appendices with public meeting materials and public resources. Staff explained the report’s framing of xylazine as both a licensed veterinary drug and an illicit drug supply contaminant, and members discussed the distinction between legal animal use and illicit importation/adulteration, with several commissioners emphasizing that people who use drugs do not intentionally seek xylazine. The commission then walked through draft findings and recommendations for best practices in oversight and enforcement, outreach and treatment, and education and training. Members discussed whether xylazine should be further scheduled or instead addressed through other public health and enforcement measures, with the draft leaning toward maintaining the current Schedule 6 status while strengthening public health responses, surveillance, drug checking, and targeted enforcement against illicit production and distribution. Commissioners also proposed stronger coordination among public safety, law enforcement, and public health, including real-time alerts, centralized data sharing, and possibly a DPH task force on emerging drug supply threats. The outreach and treatment section focused on existing harm reduction, wound care, naloxone, and mobile/low-threshold services, while noting gaps such as lack of an FDA-approved human reversal agent, geographic access barriers, insurance issues, and limited provider familiarity. A substantial portion of the meeting focused on education and training for first responders, clinicians, non-clinicians, and people who use drugs and their families. Commissioners supported tailored, stigma-free materials that cover xylazine basics, signs and symptoms, wound care, withdrawal, harm reduction, and when to seek medical care, with repeated emphasis on including firefighters, EMS, law enforcement, and other first responders in definitions and training. Members also stressed the need for consistent, centralized, and up-to-date public health data, better communication of emerging contaminants beyond xylazine, and practical guidance to prevent people with xylazine-related wounds from being turned away from care or recovery settings. The meeting ended with agreement to incorporate the feedback into a revised draft to be circulated by March 2, with another meeting scheduled for March 9 and a backup meeting later in March if needed; the commission then adjourned by unanimous motion.

Transcript Highlights:

• , the targeted pinpoint treatment for cancer treatments, and even in areas such as Alzheimer's and dementia
• , the targeted pinpoint treatment for cancer treatments, and even in areas such as Alzheimer's and dementia
• The next step was radioactive iodine treatment, which is where biomarkers come into my treatment plan
• Such programs typically cost more in the short term than a skilled nursing-based program, but if they
• Such programs typically cost more in the short term than a skilled nursing-based program, but if they

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health. Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.

Transcript Highlights:

• Effective outreach and treatment programs for patients who have been exposed to xylazine and ways to
• address any gaps that might exist in available outreach and treatment programs and services.
• programs.
• You know, often we see harm reduction outreach programs that do have some wound care treatment, but some
• That's a critical part of, I think, both treatment models and outreach and harm reduction programs: making

Keywords: 995, all

Summary: The Working Group on Outreach and Treatment of the Special Commission on Xylazine held its first meeting, chaired by Gabe Adams-Cain in Senator John Villis’s absence. Members introduced themselves and described priorities such as improving education about xylazine, expanding first responder and clinical training, and ensuring patients and providers know how to respond to xylazine-related wounds and complications. Several participants emphasized that outreach should reach both people who have not been exposed and those already affected, and that stigma is a major barrier for patients and families. Discussion focused on the main challenges to treatment and outreach, including limited awareness, inconsistent wound care access, gaps in geographic coverage, cost of supplies, and the need for better training in both outpatient and inpatient settings. Dr. Kimmel noted that harm reduction and outreach programs are already providing much of the care, but often lack specialized staff, sufficient supplies, and standardized protocols. He also said xylazine can complicate withdrawal and make it harder for people to engage in substance use treatment. Members discussed the value of non-stigmatizing, consensus messaging, family support organizations, and existing resources such as PARI, StreetCheck, and state-funded syringe service and naloxone networks. The group also reviewed the commission timeline and next steps. Staff said materials for the December 11 full commission meeting should be submitted by December 2, with draft presentation materials to be shared by December 4 and reviewed by December 9. Members agreed to do additional follow-up research on topics including the cost-effectiveness and contents of self-care wound kits, outreach to family and recovery organizations, incarcerated populations, and geographic access gaps. The meeting ended with agreement to use a PowerPoint-style presentation and to continue compiling research through a shared folder, followed by adjournment at 9:55 a.m.